Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-051847
Filing Date
2024-12-23
Accepted
2024-12-23 16:46:40
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1003926
2 ex31-1.htm EX-31.1 12329
3 ex31-2.htm EX-31.2 12097
4 ex32-1.htm EX-32.1 7038
5 ex32-2.htm EX-32.2 7018
  Complete submission text file 0001493152-24-051847.txt   5855158

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE juns-20240930.xsd EX-101.SCH 39072
7 XBRL CALCULATION FILE juns-20240930_cal.xml EX-101.CAL 46456
8 XBRL DEFINITION FILE juns-20240930_def.xml EX-101.DEF 217236
9 XBRL LABEL FILE juns-20240930_lab.xml EX-101.LAB 405876
10 XBRL PRESENTATION FILE juns-20240930_pre.xml EX-101.PRE 332577
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 781968
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41265 | Film No.: 241574486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)